Soligenix (NASDAQ: SNGX) is spotlighting new interim data on HyBryte(TM) (synthetic hypericin) for early-stage cutaneous T-cell ly ...

Press release Launch of a capital increase with preferential subscription rights for nearly 5 million euros Issuance of new shares for an initial total amount of around €5.0 million, with shareholders ...

The U.S. Army Combat Capabilities Development Command Chemical Biological Center, DEVCOM CBC, and the University of ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...

Lumos enrols 61 of required 120 bacterial positive patients in US CLIA waiver clinical study for its point-of-care ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

The Department of Health and Human Services (HHS) has canceled funding pledged to Moderna for the development of mRNA-based ...

The money, awarded last year, was intended to develop a vaccine to protect against potential pandemic influenza viruses, ...

White House National Economic Council Director Kevin Hassett insisted Thursday that Donald Trump “always wins,” even after ...

With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.